Abstract The single most important cause of severe gastroenteritis and diarrhea in young children, rotaviruses (RVs) are responsible for an annual 450,000 deaths worldwide. Despite the availability of several vaccines, RV global mortality is still high and significantly less effective in the poorest countries where the burden of disease is greatest. Therefore, there remains an urgent need for a deeper understanding of the basic mechanisms of RV pathogenesis and host-pathogen interaction to develop improved vaccines and novel antiviral therapeutics. The host protein MAVS plays a pivotal role in restricting the replication of many RNA viruses by relaying antiviral signaling from the cytoplasmic RNA sensors RIG-I and MDA5 to downstream interferon (IFN) induction. Multiple virus-encoded factors, including HCV NS3/4A, antagonize the antiviral activity of MAVS by proteolytic cleavage. We recently observed that RV infection specifically mediates the degradation of full-length MAVS but not the truncated variant mini-MAVS. This process is independent of well-characterized IFN antagonist RV NSP1. Given the importance of IFN in suppressing the replication of certain RV strains in vivo, we hypothesize that RVs utilize one or more viral proteins to dampen IFN responses by targeting MAVS signaling. We will mechanistically determine the viral and host factors responsible for MAVS degradation and examine whether it takes place in intestinal epithelial cells in vivo. The current study will broaden our knowledge of RV pathogenesis and provide a molecular basis for the rational design of a new-generation of attenuated RV vaccines.